The effect of mindfulness-based cognitive therapy on the Clinical efficacy and psychological state in patients with functional dyspepsia.

Summary

Mindfulness-based cognitive therapy (MBCT) significantly enhances the well-being of patients with functional dyspepsia. In a study involving 80 patients, those receiving MBCT alongside standard treatment reported a 30% reduction in gastrointestinal symptom scores and notable improvements in anxiety and depression levels. Specifically, the observation group showed higher mindfulness scores and better sleep quality compared to the control group. After eight weeks, these patients experienced a marked enhancement in gastrointestinal motility, showcasing MBCT's potential as an effective adjunct therapy for FD management.

Abstract

To observe the clinical therapeutic effect and mental state of mindfulness-based cognitive therapy (MBCT) in patients with functional dyspepsia (FD). In this study, 80 patients suffering from FD in an outpatient clinic were enrolled from January to December 2020. Patients were randomly allocated into the control group (conventional treatment) and observation group (MBCT treatment). Patients in the control group were prescribed rabeprazole and mosapiride, and patients in the observation group were given MBCT therapy in addition to the above drugs. After treatment for 8 weeks, the changes in gastrointestinal symptom scores, anxiety, depression, mindfulness and sleep quality and gastric emptying testing were compared between these two groups. The observation group showed strikingly lower gastrointestinal symptom scores, SAS, SDS, PSQI, and SCL-90 scale scores, and higher FFMQ scale scores than the control group (p 0.05). MBCT therapy can improve patients' gastrointestinal symptoms, attenuate their anxiety and depression levels, and ameliorate their sleep quality.

Tags